Asia Pacific Brachytherapy Market Size & Outlook
Asia Pacific brachytherapy market, 2017-2028 (US$M)
Related Markets
Asia Pacific brachytherapy market highlights
- The Asia Pacific brachytherapy market generated a revenue of USD 167.2 million in 2020.
- The market is expected to grow at a CAGR of 7.9% from 2021 to 2028.
- In terms of segment, high-dose rate (hdr) brachytherapy was the largest revenue generating dosage type in 2020.
- High-Dose Rate (HDR) Brachytherapy is the most lucrative dosage type segment registering the fastest growth during the forecast period.
- Country-wise, India is expected to register the highest CAGR from 2021 to 2028.
Asia Pacific data book summary
| Market revenue in 2020 | USD 167.2 million |
| Market revenue in 2028 | USD 307.2 million |
| Growth rate | 7.9% (CAGR from 2020 to 2028) |
| Largest segment | High-dose rate (hdr) brachytherapy |
| Fastest growing segment | High-Dose Rate (HDR) Brachytherapy |
| Historical data covered | 2017 - 2019 |
| Base year for estimation | 2020 |
| Forecast period covered | 2021 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | High-Dose Rate (HDR) Brachytherapy, Low-Dose Rate (LDR) Brachytherapy |
| Key market players worldwide | Siemens Healthineers AG ADR, Becton Dickinson & Co, Elekta AB ADR, Icad Inc, Roper Technologies Inc, Ustar, IsoRay, Eckert & Ziegler Bebig SA |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 21.2% of the global brachytherapy market in 2020.
- Globally, North America is projected to lead the regional market in terms of revenue in 2028.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 307.2 million by 2028.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Brachytherapy Market Scope
Brachytherapy Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific brachytherapy market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to brachytherapy market will help companies and investors design strategic landscapes.
High-dose rate (hdr) brachytherapy was the largest segment with a revenue share of 70.39% in 2020. Horizon Databook has segmented the Asia Pacific brachytherapy market based on high-dose rate (hdr) brachytherapy, low-dose rate (ldr) brachytherapy covering the revenue growth of each sub-segment from 2017 to 2028.
Asia Pacific brachytherapy market is expected to witness the fastest growth rate during the forecast period. Rising incidence of cancers such as prostate cancer, breast cancer, and cervical cancer is anticipated to boost the demand for brachytherapy.
According to the Economist Intelligence Unit Limited, in 2018, it was reported that the breast cancer prevalence (five year) per 100,000 was 599 in New Zealand. In addition, presence of various cancer centers in this region is expected to contribute to the market growth.
Reasons to subscribe to Asia Pacific brachytherapy market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific brachytherapy market databook
-
Our clientele includes a mix of brachytherapy market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific brachytherapy market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific brachytherapy market from 2017 to 2028, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific brachytherapy market size, by country, 2017-2028 (US$M)
Asia Pacific Brachytherapy Market Outlook Share, 2020 & 2028 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
